Este trabajo es apoyado por becas de los Institutos Canadienses de Investigación en Salud (178,918), Fonds de recherche en santé du Québec - Visión Red de Investigación de la Salud.

NOTA: Hombre C57BL / 6 ratones (5-7 semanas de edad) son de Charles River Laboratories International, Inc. (St-Constant, Quebec, Canadá.) Y manipulados de acuerdo a los protocolos aprobados por el Comité de Cuidado de Animales de Sainte-Justine CHU. Alfombrillas de explantes de tejidos bronquiales son una buena fuente de células epiteliales bronquiales primarias para la investigación de los efectos pro-apoptóticos de LMP en las células epiteliales. Este protocolo describe la generación in vitro de LMP, así como un método para detectar células epiteliales apoptóticas en explantes de tejidos bronquiales tratados con LMP. Este protocolo consiste en 3 secciones. 1. LMP producción y caracterización NOTA: Para evitar la contaminación, asegurar que todos los materiales utilizados en este experimento son estériles o en autoclave. Realice todos los pasos a TA en una cabina de seguridad biológica en condiciones estériles, a menos que se indique lo contrario. 1.1) La estimulación y percepción de los diputados9 <ol><li> Descongelar una alícuota de 10 millones de células T CEM en un baño a 37 ° C. Diluir en 10 ml pre-calentado medio libre de suero hematopoyético tales como X-Vivo, en un tubo estéril de 15 ml y centrifugar a 200 gx 5 min. Aspirar el sobrenadante y resuspender las células en 5 ml de medio de pre-calentado. </li><li> La transferencia de células en un matraz de cultivo de tejido T75 (para células en suspensión) con 15 ml de medio hematopoyético precalentado como X-VIVO e incubar durante 4 días en un incubador humidificado a 37 ° C con 5% de CO 2. </li><li> Después de 4 días, transferir todo el medio de cultivo y las células en un matraz de cultivo de tejidos T175 que contiene 100 ml de medio fresco. Continuar la incubación de las células durante aproximadamente 72 horas bajo las mismas condiciones hasta que han crecido hasta una densidad de 2 millones de células / ml. </li><li> Células uniformemente dividido entre cuatro matraces T175 cada 150 ml de medio fresco que contiene y continuar el cultivo de células hasta que las células han crecido (aproximadamente 48 h de incubación) a una densidad de 2 millones / ml. </li><li&gt; Recoger las células de cada matraz por centrifugación a 200 xg durante 5 min y resuspender 300 x 10 6 células en un nuevo frasco T175 que contiene 150 ml de medio fresco, para mantener los 2 millones / ml densidad celular. </li><li> Añadir actinomicina D (disuelto en DMSO a 2 mg / ml) al medio a una concentración final de 0,5 mg / ml y se incuba durante 24 hr. </li><li> Transferir todo el medio de cultivo en tubos de 50 ml cónicos y centrifugar las células a 750 xg durante 5 min. Transferir el sobrenadante a 50 ml tubos cónicos y se centrifuga a 1500 xg durante 15 min para eliminar los fragmentos de células grandes. </li><li> Transferir el sobrenadante en una botella de 250 ml y ultracentrífuga a 12.000 xg durante 50 min. Descartar el sobrenadante y recoger pellets. </li><li> Gránulos Wash LMPs enriquecido con PBS 40 ml estéril en un tubo de 50 ml por centrifugación a 12.000 xg durante 50 min. Repita este paso dos veces. </li><li> Recoger el último sobrenadante de lavado; que se utilizará como control del vehículo. Suspender los pellets LMPS en 1ml de PBS y transferir en un 1,5 ml microtubo estéril. Alícuotas y almacenar LMP aisladas a -80 ° C (para evitar múltiples ciclos de libre deshielo). </li></ol> 1.2) Caracterización de los diputados mediante análisis FACS 4 <ol><li> Preparar 2 muestras de tampón de anexina, 1 con y otro sin CaCl 2: Hepes 10 mM, NaCl 140 mM, más o menos 5 mM CaCl 2. </li><li> Filtra búfer anexina y FACS fluido envolvente de flujo usando un filtro de 0,22 micras para eliminar las partículas. </li><li> Diluir 1 l de LMP en 44 l de tampón de anexina con 5 mM CaCl 2 en un tubo de FACS. Preparar otro tubo con 1 l de LMP en 44 l de tampón de anexina sin CaCl 2 (control negativo). </li><li> Añadir 5 l de AnnexinV-Cy5 en cada tubo y mezclar bien. Incubar durante 15 min a TA en la oscuridad. Detener la reacción mediante la dilución de la mezcla con 400 l de FACS de fluido de funda flujo en cada tubo. </li><li> Añadir 10 l (200.000 cuentas) de 7 micras conteo beasuspensión ds como estándar interno en cada tubo para obtener un recuento absoluto. </li><li> Establecer puertas de tamaño relativo (FSC-H, PMT E00, escala logarítmica) y granularidad relativa (SSC-H, PMT 325, escala logarítmica) gráfico de puntos en el citómetro de flujo usando perlas fluorescentes de tamaño calibrado de 1 m (puerta 1) y que cuenta granos puerta a las 7 micras (puerta 2). </li><li> Analizar la muestra LMP en FSC-H / SSC-H parcela usando las puertas establecidas y FL-4 canales para anexina (PMT 765, escala logarítmica) gráfico de puntos, mediante la adquisición de una señal de hasta 20.000 contar bolas se alcanzan en la puerta 2. </li><li> Determinar los eventos AnnexinV positivos de LMP en tampón anexina contiene CaCl2, y luego restar los acontecimientos de LMP en tampón anexina sin CaCl2 (control negativo). </li><li> Calcular el número absoluto de MPs en base a la siguiente ecuación: <img alt="Ecuación 1" fo:content-width="4in" src="/files/ftp_upload/52651/52651eq1.jpg" /></li></ol> 1.3) Determinación de MP Protein Concentración (Bradford ensayo) <ol><li> Preparar 5 diluciones en serie de un estándar de proteína de 1,25 a 20 mg / ml. Pipetear 800 l de cada solución patrón y la muestra en un tubo de ensayo limpio por duplicado. Añadir 200 l de reactivo de colorante de Bradford a cada tubo. Mezclar bien, a continuación, se incuba a temperatura ambiente durante 5 min. </li><li> Medir la absorbancia a 595 nm. Determinar la concentración de proteína de LMP usando la regresión lineal de la curva estándar. </li></ol> 2. Los explantes de tejido bronquial y LMP Tratamiento NOTA: Preste especial atención al entorno de trabajo estéril y aséptica preparar las soluciones y medio utilizados en los siguientes experimentos. Para preparar la completa curación Medium, añadir 1 ml de tejido cicatricial Mediano suplementos con suero (descongelado en el hielo) a 100 ml de Tejidos Healing mediano y mezclar bien. 2.1) Preparación de explantes de tejidos bronquiales <ol><li> Antes de cultivo, rayar 6 áreas de 1 cm 2cada uno en el borde de la superficie de cada 100 mm placa de cultivo de tejidos con una hoja de bisturí. Cubra cada rascó 100 mm placa de cultivo de tejidos con 2 ml de la solución de revestimiento placa de cultivo, y se incuba el plato en un incubador de CO2 humidificado O / N a 37 ° C. Vacío aspirar la solución excedente y llenar el recipiente con 15 ml de lavado de tejidos Medio. </li><li> La eutanasia a C57BL / 6 ratones (5 a 7 semanas de edad) por inhalación de CO2 de acuerdo con los protocolos aprobados por el comité de ética del cuidado animal. </li><li> Asépticamente diseccionar el tejido pulmonar con bisturí, pinzas Dumont super fino, y tijeras quirúrgicas. Retire con cuidado parénquima y los vasos sanguíneos. Coloque el tejido pulmonar en helada Tissue Lavado Medio para el transporte al laboratorio, en su caso. </li><li> Además diseccionar bronquio sumergido en el medio de lavado de tejidos y separar el bronquio con un diámetro de 1 a 2,5 mm de tejidos pulmonares periféricos. Slice tejidos bronquiales en ~ 5 mm anillos bronquiales gruesas con un bisturí. </li&gt; <li> Use un movimiento de pala con las pinzas microdissecting curvas estériles para recoger los fragmentos bronquiales y colocarlos en las áreas rayadas de los platos. </li><li> Retire el medio de lavado de tejido, e incubar los fragmentos a temperatura ambiente durante ~ 5 min para permitir que se adhieran a los platos. </li><li> Añadir 10 ml de la cicatrización completa de medio a cada plato y colocarlos en una cámara incubadora modular atmósfera controlada. Enjuague con la cámara de alta mezcla de gas O 2 (70% O 2, 25% de N 2 y 5% de CO 2,). Coloque la cámara en una incubadora orbital de sobremesa y agitar a 37 ° C. Agitar la cámara durante 24 horas a 10 ciclos por minuto para permitir que el medio fluya intermitentemente a través de los fragmentos. </li><li> Después de 24 horas de incubación, observar los explantes de tejido bajo un microscopio óptico de contraste de fase invertida. Seleccione explantes bronquiales con movimiento completo, pelo fino y animado epitelio bronquial para el tratamiento LMP posterior. </li></ol>2.2) Tratamiento LMP <ol><li> Preparar medio de crecimiento completo de la siguiente manera: crecimiento deshielo suplementos medianas con inhibidor de suero y fibroblastos en hielo. Añadir 1 ml de los suplementos de medio de crecimiento con suero y 200 inhibidor de fibroblastos l a 100 ml de medio de crecimiento; mezclar bien. Calentar el medio de crecimiento completo a 37 ° C durante 10 min antes de usar. </li><li> Diluir LMPs aislados en un nuevo tubo eppendorf estéril con PBS para preparar una acción LMPs a una concentración de 800 mg / ml. </li><li> Añadir 0,5 ml de medio completo de crecimiento a cada pocillo de una placa de cultivo de tejido de 12 pocillos. </li><li> La transferencia de los explantes bronquiales seleccionados con las pinzas microdissecting curvas del protocolo anterior (sección 2.1) a cada pocillo de la placa de cultivo de tejidos. </li><li> Etiqueta de la placa de cultivo apropiado para identificar pozos de tratamiento LMPS y pozos de control. Añadir 25 l de stock LMP en cada tratamiento LMPs bien (para una concentración final de 40 mg / ml) y 25 l vehículo de control (véase LMP<html> producción s) a los pocillos de control. </li><li> Continuar la incubación en una cámara incubadora modular atmósfera controlada a 37 ° C con agitación suave. </li><li> Después de 24 horas, lavar explantes 3 veces con PBS y se procederá a la (fijación paraformaldehído al 4% [PFA]) siguiente paso. </li></ol> 3. El examen histopatológico 3.1) Preparar las siguientes soluciones antes de proceder a los próximos pasos <ol><li> Preparar tampón PBS 1x mezclando NaCl 137 mM, 2,7 mM KCl, 10 mM Na 2 HPO 4, 1,76 mM KH 2 PO 4, pH 7,4. </li><li> Para preparar 4% PFA, se disuelven 20 g de PFA en 400 ml de agua, se calentó a 60 ° C con agitación; añadir unas gotas de NaOH 10 M para borrar la solución. A continuación añadimos tampón PBS 1x y ajustar el volumen a 500 ml y el pH a 7,4. Filtro y alícuota; almacenar a -20 ° C. </li><li> Prepare los siguientes reactivos de deshidratación o de rehidratación; 100%, 90%, 70%, 50% de etanol y xileno. </li></ol>e_step &quot;&gt; 3.2) Explante Fijación y Tejidos Sección desparafinización <ol><li> Coloque cada explante en un tubo de microcentrífuga marcado con 1,5 ml de PFA al 4% y se incuba O / N a 4 ° C. Enjuague los explantes dos veces con PBS 1x. </li><li> Deshidratar explantes a través de una serie de alcohol (etanol 70%: 3 veces 30 minutos cada uno; etanol al 90%: 2 veces 30 minutos cada uno; etanol al 100%: 3 veces 30 min cada uno, y luego xileno: 3 veces 20 min cada uno). Realice todos los pasos a TA en una campana de humos. </li><li> Imbed explantes de tejidos en parafina a 58 ° C en un horno. Preparar 5 micras secciones de tejido de espesor usando un micrótomo rotatorio. </li><li> Flotador las secciones en un 56 ° C baño de agua, y luego montar las secciones en portaobjetos histológicos etiquetados. Colocar los portaobjetos en bastidores de tinción manuales y seco a 65 ° C durante 1 hora. Permita que las diapositivas se enfríen a temperatura ambiente. </li><li> Sumerja los bastidores en 4 platos mancha consecutivas que contienen xileno durante 10 minutos cada uno para eliminar la parafina. Sumergir los bastidores en una serie de etanol para eliminar el xileno: 100%, luego 95%, THes 80%, entonces el 70%, luego etanol al 50% (5 minutos por cada paso). Enjuague los bastidores con agua del grifo durante 5 min para eliminar el etanol. </li></ol> 3.3) hematoxilina y eosina (H &amp; E) tinción <ol><li> Continuar trabajando con las secciones de tejido fijadas; coloque el estante en una placa de tinción de llenado con hematoxilina de Mayer durante 15 min. Enjuague la rejilla con agua del grifo para eliminar hematoxilina durante 20 min. </li><li> Colocar en agua destilada durante 30 sec.Place en etanol al 95% durante 30 seg. Colocar en Eosina Y placa de tinción de solución durante 1 min. Deshidratar a través de 2 cambios de etanol 95%, etanol al 100%, y xileno para 2 min cada uno. </li><li> Realice una comprobación rápida con un microscopio para asegurarse de que se elimina el exceso eosina. Coloque 2 a 3 gotas de medio de montaje (Fisher SP15-100) en cada diapositiva, luego cubra con una tapa de vidrio. </li></ol> 3.4) En Detección Muerte Situ Cell: Ensayo de TUNEL <ol><li> Antes de empezar, preparar la solución de trabajo de proteinasa K: 20 g / ml enTris 10 mM / HCl, pH 7,4. </li><li> Repita los pasos 1 a 5 de la sección 3.2 (fijación del explante y la sección de deparaffinization tejido). Enjuagar los portaobjetos con desionizada H 2 O. </li><li> Sumergir los portaobjetos con PBS 1x durante 10 min. Escurrir el exceso de PBS. Incubar las secciones de tejido durante 30 min a RT con solución de trabajo de proteinasa K. Enjuague desliza dos veces con PBS 1x. </li><li> Lleve a cabo el ensayo de TUNEL como se describe en el manual de instrucciones de kit de detección de muerte celular. Montar utilizando medio de montaje y cubreobjetos manualmente con cubreobjetos de vidrio. </li><li> Analizar las muestras en un microscopio de luz. Utilice Image Pro 4.5 para analizar las células apoptóticas en el color marrón. </li></ol>

<ol>
	<li>Tushuizen, M. E., Diamant, M., Sturk, A., Nieuwland, R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Cell-derived+microparticles+in+the+pathogenesis+of+cardiovascular+disease:+friend+or+foe.">Cell-derived microparticles in the pathogenesis of cardiovascular disease: friend or foe.</a> Arterioscler Thromb Vasc Biol. 31 (1), 4-9 (2011).</li><li>Martinez, M. C., Tual-Chalot, S., Leonetti, D., Andriantsitohaina, R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Microparticles:+targets+and+tools+in+cardiovascular+disease.">Microparticles: targets and tools in cardiovascular disease.</a> Trends Pharmacol Sci. 32 (11), 659-665 (2011).</li><li>Benameur, T., Andriantsitohaina, R., Martinez, M. C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Therapeutic+potential+of+plasma+membrane-derived+microparticles.">Therapeutic potential of plasma membrane-derived microparticles.</a> Pharmacol Rep. 61 (1), 49-57 (2009).</li><li>Yang, C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Lymphocytic+microparticles+inhibit+angiogenesis+by+stimulating+oxidative+stress+and+negatively+regulating+VEGF-induced+pathways.">Lymphocytic microparticles inhibit angiogenesis by stimulating oxidative stress and negatively regulating VEGF-induced pathways.</a> Am J Physiol Regul Integr Comp Physiol. 294 (2), 467-476 (2008).</li><li>Yang, C., Gagnon, C., Hou, X., Hardy, P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Low+density+lipoprotein+receptor+mediates+anti-VEGF+effect+of+lymphocyte+T-derived+microparticles+in+Lewis+lung+carcinoma+cells.">Low density lipoprotein receptor mediates anti-VEGF effect of lymphocyte T-derived microparticles in Lewis lung carcinoma cells.</a> Cancer Biol Ther. 10 (5), 448-456 (2010).</li><li>Angelillo-Scherrer, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Leukocyte-derived+microparticles+in+vascular+homeostasis.">Leukocyte-derived microparticles in vascular homeostasis.</a> Circ Res. 110 (2), 356-369 (2012).</li><li>Maeno, T., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=CD8++T+Cells+are+required+for+inflammation+and+destruction+in+cigarette+smoke-induced+emphysema+in+mice.">CD8+ T Cells are required for inflammation and destruction in cigarette smoke-induced emphysema in mice.</a> J Immunol. 178 (12), 8090-8096 (2007).</li><li>Qiu, Q., Xiong, W., Yang, C., Gagnon, C., Hardy, P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Lymphocyte-derived+microparticles+induce+bronchial+epithelial+cells'+pro-inflammatory+cytokine+production+and+apoptosis.">Lymphocyte-derived microparticles induce bronchial epithelial cells' pro-inflammatory cytokine production and apoptosis.</a> Mol Immunol. 55 (3-4), 220-230 (2013).</li><li>Martin, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Shed+membrane+particles+from+T+lymphocytes+impair+endothelial+function+and+regulate+endothelial+protein+expression.">Shed membrane particles from T lymphocytes impair endothelial function and regulate endothelial protein expression.</a> Circulation. 109 (13), 1653-1659 (2004).</li><li>Shet, A. S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Sickle+blood+contains+tissue+factor-positive+microparticles+derived+from+endothelial+cells+and+monocytes.">Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes.</a> Blood. 102 (7), 2678-2683 (2003).</li><li>Mause, S. F., Weber, C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Microparticles:+protagonists+of+a+novel+communication+network+for+intercellular+information+exchange.">Microparticles: protagonists of a novel communication network for intercellular information exchange.</a> Circ Res. 107 (9), 1047-1057 (2010).</li><li>Yang, C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Anti-proliferative+and+anti-tumour+effects+of+lymphocyte-derived+microparticles+are+neither+species-+nor+tumour-type+specific.">Anti-proliferative and anti-tumour effects of lymphocyte-derived microparticles are neither species- nor tumour-type specific.</a> J Extracell Vesicles. 3, (2014).</li><li>Soleti, R., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Microparticles+harboring+Sonic+Hedgehog+promote+angiogenesis+through+the+upregulation+of+adhesion+proteins+and+proangiogenic+factors.">Microparticles harboring Sonic Hedgehog promote angiogenesis through the upregulation of adhesion proteins and proangiogenic factors.</a> Carcinogenesis. 30 (4), 580-588 (2009).</li></ol>

Los autores no tienen nada que revelar.

Los diputados son mediadores activos de diafonía intercelular y su estudio es la promesa en muchas áreas de la ciencia. 11 Este estudio presenta un protocolo detallado para la generación a gran escala in vitro de LMP derivado de una línea de células T apoptóticas. Estas MPs expresan un gran repertorio de moléculas de linfocitos y están biológicamente implicados en la regulación de la homeostasis celular y tisular. Sin embargo, LMPs procedente de diferentes fuentes puede ser biológicamente ...

Microparticles (MPs) are biologically active submicron membrane vesicles released following cell activation or apoptosis. MPs are derived from both healthy and damaged cells and are implicated in many physiological and pathological processes.1 MPs have been detected not only in human plasma, but also in inflammatory and apoptotic tissue. The biological utility of cell membrane&#8211;derived MPs has been demonstrated in various settings, including cell signalling models and as pharmacological tools.2,3 We previously demonstrated that LMPs derived from T lymphocytes following actinomycin D stimulation (to induce apoptosis) suppress angiogenesis and inhibit endothelial cell survival and proliferation.4,5 The antiangiogenic effects of LMPs may vary significantly depending on the stimuli used to activate T lymphocytes in vitro.6
The airway epithelium functions as a protective physical and functional barrier. Increased numbers of T lymphocytes in the airway can contribute to cell damage and airway inflammation.7 We have shown that LMPs induce apoptosis of human bronchial epithelial cells,8 which indicated LMPs may change barrier function of bronchial epithelium in vivo. Apoptotic cells can be identified using the TUNEL method, which detects in situ DNA fragmentation. 
The overall goal of this protocol is to illustrate the in vitro production of LMPs from a T lymphocyte cell line, and to demonstrate their proapoptotic effect on airway epithelial cells. In situ cell death detection demonstrated that LMPs strongly induce airway bronchial epithelial cell death, suggesting that LMPs-mediated injury to the airway epithelium may impact barrier function of the damaged epithelium.

<table border="0" cellpadding="0" cellspacing="0" width="828">
	<tbody>
		<tr height="21">
			<td height="21" style="height:21px;width:303px;">LMPs production and characterization</td>
			<td style="width:231px;"></td>
			<td style="width:124px;"></td>
			<td style="width:171px;"></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">CEM T cells&#160;</td>
			<td style="width:231px;">ATCC&#160;</td>
			<td style="width:124px;">CCL-119</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:303px;">X-VIVO 15 medium&#160;</td>
			<td style="width:231px;">Cambrex, Walkersville</td>
			<td>04-744Q</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:303px;">Flask T75</td>
			<td style="width:231px;">Sarstedt</td>
			<td style="width:124px;">83.1813.502</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:303px;">Flask T175</td>
			<td style="width:231px;">Sarstedt</td>
			<td style="width:124px;">83.1812.502</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Actinomycin&#160;D&#160;</td>
			<td style="width:231px;">Sigma Chemical Co.</td>
			<td style="width:124px;">A9415-2mg</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:303px;">PBS</td>
			<td style="width:231px;">Lifetechnologies</td>
			<td>14190-144</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">0.22&#181;m filter</td>
			<td style="width:231px;">Sarstedt</td>
			<td style="width:124px;">83.1826.001</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:303px;">Annexin-VCy5</td>
			<td style="width:231px;">BD Pharmagen&#160;</td>
			<td>559933</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">FACS flow solution</td>
			<td>BD Bio-sciences</td>
			<td style="width:124px;">342003</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:303px;">Fluorescent microbeads (1 um)</td>
			<td style="width:231px;">Molecular Probes&#160;</td>
			<td style="width:124px;">T8880</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Polysterene counting beads (7 um)</td>
			<td style="width:231px;">Bangs laboratories</td>
			<td style="width:124px;">PS06N/6994</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Polypropylene FACS tubes</td>
			<td>Falcon</td>
			<td style="width:124px;">352058</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:303px;">1 ml pipet</td>
			<td style="width:231px;">Fisher</td>
			<td style="width:124px;">13-678-11B</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:303px;">5 ml pipet</td>
			<td style="width:231px;">Falcon</td>
			<td style="width:124px;">357543</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:303px;">25 ml pipet</td>
			<td style="width:231px;">Ultident</td>
			<td style="width:124px;">DL-357551</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:303px;">1,5 ml conical polypropylene micro tube</td>
			<td style="width:231px;">Sarstedt</td>
			<td style="width:124px;">72.690</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:303px;">15 ml conical polypropylene tube</td>
			<td style="width:231px;">Sarstedt</td>
			<td style="width:124px;">62.554.205</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:303px;">50 ml conical polypropylene tube</td>
			<td style="width:231px;">Sarstedt</td>
			<td style="width:124px;">62.547.205</td>
			<td></td>
		</tr>
		<tr height="42">
			<td height="42" style="height:42px;width:303px;">50 ml high speed polypropylene copolymer tube</td>
			<td style="width:231px;">Nalgene</td>
			<td style="width:124px;">3119-0050</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:303px;">250 ml high speed polypropylene bottle</td>
			<td style="width:231px;">Beckman</td>
			<td style="width:124px;">356011</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Protein assay (Bradford assay)</td>
			<td>Bio-Rad Laboratories</td>
			<td>500-0006</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Protein assay standard II</td>
			<td>Bio-Rad Laboratories</td>
			<td>500-0007</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Test tube 16x100</td>
			<td>VWR</td>
			<td>47729-576</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Test tube 12x75</td>
			<td>Ultident</td>
			<td>170-14100005B</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Cell incubator&#160;</td>
			<td style="width:231px;">Mandel</td>
			<td style="width:124px;">Heracell 150</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:303px;">Low speed centrifuge</td>
			<td style="width:231px;">IEC</td>
			<td style="width:124px;">Centra8R</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:303px;">High speed centrifuge</td>
			<td style="width:231px;">Beckman</td>
			<td style="width:124px;">Avanti J8</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:303px;">High speed rotor for 250ml bottle</td>
			<td style="width:231px;">Beckman</td>
			<td style="width:124px;">JLA16.250</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:303px;">High speed rotor for 50ml tube</td>
			<td style="width:231px;">Beckman</td>
			<td style="width:124px;">JA30.50</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Fow cytometry&#160;</td>
			<td>BD Bio-sciences</td>
			<td style="width:124px;">FACS Calibur</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:303px;">Spectrophotometer</td>
			<td style="width:231px;">Beckman</td>
			<td style="width:124px;">Series 600</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:303px;"></td>
			<td style="width:231px;"></td>
			<td style="width:124px;"></td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Bronchial tissue explants and sections&#160;</td>
			<td style="width:231px;"></td>
			<td style="width:124px;"></td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">C57BL/6 mice (5-7 weeks old)&#160;&#160;</td>
			<td style="width:231px;">Charles River Laboratories, Inc.&#160;</td>
			<td style="width:124px;"></td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Mouse Airway PrimaCell&#8482; System:</td>
			<td style="width:231px;">CHI Scientific, Inc.</td>
			<td style="width:124px;">2-82001</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">&#160;Rib-Back Carbon Steel Scalpel Blades</td>
			<td style="width:231px;">Becton Dickinson AcuteCare</td>
			<td style="width:124px;">371310</td>
			<td>#10</td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Scalpel Handle</td>
			<td style="width:231px;">Fine Science Tools Inc.&#160;</td>
			<td style="width:124px;">10003-12</td>
			<td>#7</td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">phase-contrast inverted microscope</td>
			<td style="width:231px;">Olympus Optical CO., LTD.&#160;&#160;&#160;</td>
			<td style="width:124px;">CK2</td>
			<td></td>
		</tr>
		<tr height="25">
			<td height="25" style="height:25px;">high O2 gas mixture&#160;</td>
			<td>VitalAire Canada Inc.</td>
			<td style="width:124px;"></td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:303px;">modular incubator chamber</td>
			<td style="width:231px;">Billups-Rothenberg Inc.</td>
			<td style="width:124px;">MIC-101</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">MaxQ 4000 incubated orbital shaker</td>
			<td style="width:231px;">Barnstead Lab-Line,&#160;</td>
			<td style="width:124px;">SHKA4000-7</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">12-well tissue culture plate</td>
			<td style="width:231px;">Becton Dickinson and Company</td>
			<td style="width:124px;">353043</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:303px;">Plastic tissue culture dishes (100 mm)</td>
			<td style="width:231px;">Sarstedt, Inc.</td>
			<td style="width:124px;">83.1802</td>
			<td></td>
		</tr>
		<tr height="42">
			<td height="42" style="height:42px;width:303px;">Surgical scissors</td>
			<td style="width:231px;">Fine Science Tools Inc.&#160;</td>
			<td style="width:124px;">14060-09</td>
			<td style="width:171px;">Straight, sharp, 9cm longth</td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:303px;">Half-curved Graefe forceps</td>
			<td style="width:231px;">Fine Science Tools Inc.&#160;</td>
			<td style="width:124px;">11052-10</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:303px;">humidified CO2 incubator</td>
			<td style="width:231px;">Mandel Scientific Company Inc.&#160;</td>
			<td style="width:124px;">SVH-51023421</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:303px;"></td>
			<td style="width:231px;"></td>
			<td style="width:124px;"></td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">&#160;Histopathological examination&#160;</td>
			<td style="width:231px;"></td>
			<td style="width:124px;"></td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">formalin formaldehyde</td>
			<td style="width:231px;">Sigma-Aldrich, Inc.&#160;</td>
			<td style="width:124px;">HT5011</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">paraffin</td>
			<td style="width:231px;">Fisher scientific&#160; International, Inc.</td>
			<td style="width:124px;">T555</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">ethyl alcohol</td>
			<td style="width:231px;">Merck KGaA, Darmstadt</td>
			<td style="width:124px;">EX0278-1</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">&#160;glutaraldehyde&#160;</td>
			<td style="width:231px;">Sigma-Aldrich, Inc.&#160;</td>
			<td style="width:124px;">G6403</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Cacodylate</td>
			<td style="width:231px;">Sigma-Aldrich, Inc.&#160;</td>
			<td style="width:124px;">31533</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">microscope slides</td>
			<td style="width:231px;">VWR Scientific Inc.&#160;</td>
			<td style="width:124px;">48300-025</td>
			<td>25x75mm</td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Xylene</td>
			<td style="width:231px;">Fisher scientific&#160; International, Inc.</td>
			<td style="width:124px;">X5-4</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Mayer&#39;s hematoxylin</td>
			<td style="width:231px;">Sigma-Aldrich, Inc.&#160;</td>
			<td style="width:124px;">MHS16</td>
			<td>Funnel with filter paper&#160;&#160;</td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">HCl&#160;</td>
			<td style="width:231px;">Fisher scientific&#160; International, Inc.&#160;&#160;</td>
			<td style="width:124px;">A144s-500</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">eosin&#160;</td>
			<td style="width:231px;">Sigma-Aldrich, Inc.&#160;</td>
			<td style="width:124px;">HT110116</td>
			<td>Funnel with filter paper&#160;&#160;</td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Permount&#8482; Mounting Medium</td>
			<td style="width:231px;">Thermo Fisher Scientific Inc.&#160;</td>
			<td>SP15-100</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">glass coverslip</td>
			<td style="width:231px;">surgipath medical industries, Inc.</td>
			<td style="width:124px;">84503</td>
			<td>24&#215;24&#160;#1&#160;</td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">TUNEL detection kit</td>
			<td style="width:231px;">In Situ Cell Death Detection, POD</td>
			<td style="width:124px;">11 684 817 910</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">oven</td>
			<td style="width:231px;">Despatch Industries Inc.</td>
			<td style="width:124px;">LEB-1-20</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:303px;">rotary Microtome</td>
			<td style="width:231px;">Leica Microsystems Inc.</td>
			<td style="width:124px;">RM2145</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:303px;">filter paper</td>
			<td style="width:231px;">Whatman International Ltd.</td>
			<td style="width:124px;">1003150</td>
			<td>#3</td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Microscope</td>
			<td style="width:231px;">Nikon Imaging Japan Inc.</td>
			<td style="width:124px;">E800</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">staining dish complete</td>
			<td style="width:231px;">Wheaton Industries, Inc.</td>
			<td>900200</td>
			<td>including dish, rack, cover</td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:303px;">1.5 ml eppendorf tube</td>
			<td style="width:231px;">Sarstedt Inc.&#160;</td>
			<td style="width:124px;">72.69</td>
			<td>39x10mm</td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Orbital and Reciprocating Water Bath</td>
			<td style="width:231px;">ExpotechUSA</td>
			<td style="width:124px;">ORS200</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">phosphate buffered saline&#160;&#160;</td>
			<td style="width:231px;">GIBCO</td>
			<td style="width:124px;">14190-144</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">fume hood</td>
			<td>Nicram RD Service</td>
			<td>3707E</td>
			<td></td>
		</tr>
	</tbody>
</table>

generation of lymphocytic microparticles and detection of their proapoptotic effect on airway epithelial cells

El interés en las funciones biológicas de las vesículas de membrana derivadas de células en la comunicación celular se ha incrementado en los últimos años. Las micropartículas (MP) son un tal tipo de vesículas, que varían en diámetro desde 0,1 m a 1 m, y normalmente se desprenden de la membrana plasmática de las células eucariotas se someten a la activación o la apoptosis. Aquí se describe la generación de linfocitos T derivados de micropartículas (LMP) a partir de células CEM T apoptóticas estimulados con actinomicina D. LMP están aisladas a través de un proceso de centrifugación diferencial de varios pasos y que se caracteriza por citometría de flujo. Este protocolo también presenta un método de detección in situ la muerte celular para demostrar el efecto proapoptótico de LMP en las células epiteliales bronquiales derivados de ratón explantes de tejidos bronquiales respiratorias primarias. Los métodos descritos en este documento proporcionan un procedimiento reproducible para el aislamiento de cantidades abundantes de LMP a partir de linfocitos apoptóticos in vitro. LMP derivade esta manera se puede utilizar para evaluar las características de varios modelos de enfermedad, y para la farmacología y pruebas de toxicología. Dado que el epitelio de la vía aérea ofrece una barrera física y funcional de protección entre el ambiente externo y el tejido subyacente, el uso de explantes de tejidos bronquiales en lugar de líneas de células epiteliales inmortalizadas ofrece un modelo eficaz para investigaciones que requieran tejido del tracto de las vías respiratorias.

LMP se caracterizaron con la tinción de anexina V 10 por fluorescencia de células activadas por la clasificación análisis (FACS) y cerrada usando 1 micras cuentas en las que el 97% de los diputados (≤1 m) fueron anexina-V-Cy5 positivo (Figura 1A y 1B). Por lo general, se obtuvieron alrededor de 2,5 mg de LMP siguiendo este protocolo. Explantes de tejidos bronquiales de C57BL / 6 ratones fueron sometidos a vehículo y el tratamiento LMP. El análisis histopatológico de las secciones bro...

Watch this Scientific Journal Video about Generation of Lymphocytic Microparticles and Detection of their Proapoptotic Effect on Airway Epithelial Cells at JoVE.com

Generation of Lymphocytic Microparticles and Detection of their Proapoptotic Effect on Airway Epithelial Cells

Micropartículas membrana arrojar celulares (MPs) son vesículas biológicas activas que pueden ser aislados y sus efectos fisiopatológicos investigados en varios modelos. Aquí se describe un método para generar MPs derivadas de los linfocitos T (LMP) y para demostrar su efecto proapoptótico en células epiteliales de las vías respiratorias.

Generación de linfocítica micropartículas y detección de su efecto proapoptótico sobre las células epiteliales de la vía aérea

Interest in the biological roles of cell membrane&#8211;derived vesicles in cell&#8211;cell communication has increased in recent years. Microparticles ...

generation-lymphocytic-microparticles-detection-their-proapoptotic

Research

JoVE Journal

Immunology and Infection

8.9K vistas.  University of Montréal.  Micropartículas membrana arrojar celulares (MPs) son vesículas biológicas activas que pueden ser aislados y sus efectos fisiopatológicos investigados en varios modelos. Aquí se describe un método para generar MPs derivadas de los linfocitos T (LMP) y para demostrar su efecto proapoptótico en células epiteliales de las vías respiratorias. 

Video: Generation of Lymphocytic Microparticles and Detection of their Proapoptotic Effect on Airway Epithelial Cells

Co-culture Models of Pseudomonas aeruginosa Biofilms Grown on Live Human Airway Cells

Bacterial biofilms have been associated with a number of different human diseases, but biofilm development has generally been studied on non-living surfaces. In this paper, we describe protocols for forming Pseudomonas aeruginosa biofilms on human airway epithelial cells (CFBE cells) grown in culture. In the first method (termed the Static Co-culture Biofilm Model), P. aeruginosa is incubated with CFBE cells grown as confluent monolayers on standard tissue culture plates. Although the bacterium is quite toxic to epithelial cells, the addition of arginine delays the destruction of the monolayer long enough for biofilms to form on the CFBE cells. The second method (termed the Flow Cell Co-culture Biofilm Model), involves adaptation of a biofilm flow cell apparatus, which is often used in biofilm research, to accommodate a glass coverslip supporting a confluent monolayer of CFBE cells. This monolayer is inoculated with P. aeruginosa and a peristaltic pump then flows fresh medium across the cells. In both systems, bacterial biofilms form within 6-8 hours after inoculation. Visualization of the biofilm is enhanced by the use of P. aeruginosa strains constitutively expressing green fluorescent protein (GFP). The Static and Flow Cell Co-culture Biofilm assays are model systems for early P. aeruginosa infection of the Cystic Fibrosis (CF) lung, and these techniques allow different aspects of P. aeruginosa biofilm formation and virulence to be studied, including biofilm cytotoxicity, measurement of biofilm CFU, and staining and visualizing the biofilm.

Co-culture Models of Pseudomonas aeruginosa Biofilms Grown on Live Human Airway Cells

This paper describes different methods of growing Pseudomonas aeruginosa biofilms on cultured human airway epithelial cells. These protocols can be adapted to study different aspects of biofilm formation, including visualization of the biofilm, staining of the biofilm, measuring the colony forming units (CFU) of the biofilm, and studying biofilm cytotoxicity.

Los modelos de co-cultivo de Pseudomonas aeruginosa Biofilms Cultivado en las células vivas las vías respiratorias humanas

Bacterial biofilms have been associated with a number of different human diseases, but biofilm development has generally been studied on non-living ...

Investigación

Inmunología e Infección

Combination of Adhesive-tape-based Sampling and Fluorescence in situ Hybridization for Rapid Detection of Salmonella on Fresh Produce

This protocol describes a simple approach for adhesive-tape-based sampling of tomato and other fresh produce surfaces, followed by on-tape fluorescence in situ hybridization (FISH) for rapid culture-independent detection of Salmonella spp. Cell-charged tapes can also be placed face-down on selective agar for solid-phase enrichment prior to detection. Alternatively, low-volume liquid enrichments (liquid surface miniculture) can be performed on the surface of the tape in non-selective broth, followed by FISH and analysis via flow cytometry. To begin, sterile adhesive tape is brought into contact with fresh produce, gentle pressure is applied, and the tape is removed, physically extracting microbes present on these surfaces. Tapes are mounted sticky-side up onto glass microscope slides and the sampled cells are fixed with 10% formalin (30 min) and dehydrated using a graded ethanol series (50, 80, and 95%; 3 min each concentration). Next, cell-charged tapes are spotted with buffer containing a Salmonella-targeted DNA probe cocktail and hybridized for 15 - 30 min at 55&deg;C, followed by a brief rinse in a washing buffer to remove unbound probe. Adherent, FISH-labeled cells are then counterstained with the DNA dye 4',6-diamidino-2-phenylindole (DAPI) and results are viewed using fluorescence microscopy. For solid-phase enrichment, cell-charged tapes are placed face-down on a suitable selective agar surface and incubated to allow in situ growth of Salmonella microcolonies, followed by FISH and microscopy as described above. For liquid surface miniculture, cell-charged tapes are placed sticky side up and a silicone perfusion chamber is applied so that the tape and microscope slide form the bottom of a water-tight chamber into which a small volume (&le; 500 &mu;L) of Trypticase Soy Broth (TSB) is introduced. The inlet ports are sealed and the chambers are incubated at 35 - 37&deg;C, allowing growth-based amplification of tape-extracted microbes. Following incubation, inlet ports are unsealed, cells are detached and mixed with vigorous back and forth pipetting, harvested via centrifugation and fixed in 10% neutral buffered formalin. Finally, samples are hybridized and examined via flow cytometry to reveal the presence of Salmonella spp. As described here, our "tape-FISH" approach can provide simple and rapid sampling and detection of Salmonella on tomato surfaces. We have also used this approach for sampling other types of fresh produce, including spinach and jalape&ntilde;o peppers.

Combination of Adhesive-tape-based Sampling and Fluorescence in situ Hybridization for Rapid Detection of Salmonella on Fresh Produce

This protocol describes a simple adhesive-tape-based approach for sampling of tomato and other fresh produce surfaces, followed by rapid whole cell detection of Salmonella using fluorescence in situ hybridization (FISH).

Combinación de adhesivo basado en cinta de muestreo y de fluorescencia In situ La hibridación para la detección rápida de Salmonella En los productos frescos

This protocol describes a simple approach for adhesive-tape-based sampling of tomato and other fresh produce surfaces, followed by on-tape fluorescence in ...

Application of a Mouse Ligated Peyer&#x2019;s Patch Intestinal Loop Assay to Evaluate Bacterial Uptake by M cells

The inside of our gut is inhabited with enormous number of commensal bacteria. The mucosal surface of the gastrointestinal tract is continuously exposed to them and occasionally to pathogens. The gut-associated lymphoid tissue (GALT) play a key role for induction of the mucosal immune response to these microbes1, 2. To initiate the mucosal immune response, the mucosal antigens must be transported from the gut lumen across the epithelial barrier into organized lymphoid follicles such as Peyer's patches. This antigen transcytosis is mediated by specialized epithelial M cells3, 4. M cells are atypical epithelial cells that actively phagocytose macromolecules and microbes. Unlike dendritic cells (DCs) and macrophages, which target antigens to lysosomes for degradation, M cells mainly transcytose the internalized antigens. This vigorous macromolecular transcytosis through M cells delivers antigen to the underlying organized lymphoid follicles and is believed to be essential for initiating antigen-specific mucosal immune responses. However, the molecular mechanisms promoting this antigen uptake by M cells are largely unknown. We have previously reported that glycoprotein 2 (Gp2), specifically expressed on the apical plasma membrane of M cells among enterocytes, serves as a transcytotic receptor for a subset of commensal and pathogenic enterobacteria, including Escherichia coli and Salmonella enterica serovar Typhimurium (S. Typhimurium), by recognizing FimH, a component of type I pili on the bacterial outer membrane 5. Here, we present a method for the application of a mouse Peyer's patch intestinal loop assay to evaluate bacterial uptake by M cells. This method is an improved version of the mouse intestinal loop assay previously described 6, 7. The improved points are as follows: 1. Isoflurane was used as an anesthetic agent. 2. Approximately 1 cm ligated intestinal loop including Peyer's patch was set up. 3. Bacteria taken up by M cells were fluorescently labeled by fluorescence labeling reagent or by overexpressing fluorescent protein such as green fluorescent protein (GFP). 4. M cells in the follicle-associated epithelium covering Peyer's patch were detected by whole-mount immunostainig with anti Gp2 antibody. 5. Fluorescent bacterial transcytosis by M cells were observed by confocal microscopic analysis. The mouse Peyer's patch intestinal loop assay could supply the answer what kind of commensal or pathogenic bacteria transcytosed by M cells, and may lead us to understand the molecular mechanism of how to stimulate mucosal immune system through M cells.

Application of a Mouse Ligated Peyer&amp;#8217;s Patch Intestinal Loop Assay to Evaluate Bacterial Uptake by M cells

M cells in a specialized follicle-associated epithelium covering Peyer&#x2019;s patches play an important role for the mucosal immunosurveillance in gut-associated lymphoid tissue. Here we described the evaluation method for bacterial transcytosis by M cells in vivo. This method provides a method to understand M-cell function in the immune system.

La aplicación de un ratón ligado Ensayo placas de Peyer asa intestinal para evaluar la absorción por las células bacterianas M

The inside of our gut is inhabited with enormous number of commensal bacteria. The mucosal surface of the gastrointestinal tract is continuously exposed ...

Establishing a Liquid-covered Culture of Polarized Human Airway Epithelial Calu-3 Cells to Study Host Cell Response to Respiratory Pathogens In vitro

The apical and basolateral surfaces of airway epithelial cells demonstrate directional responses to pathogen exposure in vivo. Thus, ideal in vitro models for examining cellular responses to respiratory pathogens polarize, forming apical and basolateral surfaces. One such model is differentiated normal human bronchial epithelial cells (NHBE). However, this system requires lung tissue samples, expertise isolating and culturing epithelial cells from tissue, and time to generate an air-liquid interface culture.
Calu-3 cells, derived from a human bronchial adenocarcinoma, are an alternative model for examining the response of proximal airway epithelial cells to respiratory insult1, pharmacological compounds2-6, and bacterial7-9 and viral pathogens, including influenza virus, rhinovirus and severe acute respiratory syndrome - associated coronavirus10-14. Recently, we demonstrated that Calu-3 cells are susceptible to respiratory syncytial virus (RSV) infection in a manner consistent with NHBE15,16 . Here, we detail the establishment of a polarized, liquid-covered culture (LCC) of Calu-3 cells, focusing on the technical details of growing and culturing Calu-3 cells, maintaining cells that have been cultured into LCC, and we present the method for performing respiratory virus infection of polarized Calu-3 cells.
To consistently obtain polarized Calu-3 LCC, Calu-3 cells must be carefully subcultured before culturing in Transwell inserts. Calu-3 monolayer cultures should remain below 90% confluence, should be subcultured fewer than 10 times from frozen stock, and should regularly be supplied with fresh medium. Once cultured in Transwells, Calu-3 LCC must be handled with care. Irregular media changes and mechanical or physical disruption of the cell layers or plates negatively impact polarization for several hours or days. Polarization is monitored by evaluating trans-epithelial electrical resistance (TEER) and is verified by evaluating the passive equilibration of sodium fluorescein between the apical and basolateral compartments17,18 . Once TEER plateaus at or above 1,000 &Omega;&times;cm2, Calu-3 LCC are ready to use to examine cellular responses to respiratory pathogens.

Establishing a Liquid-covered Culture of Polarized Human Airway Epithelial Calu-3 Cells to Study Host Cell Response to Respiratory Pathogens In vitro

The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.

El establecimiento de un cultivo líquido cubierto de las vías respiratorias humanas epiteliales polarizadas Calu-3 células para estudiar la respuesta del huésped celular a patógenos respiratorios<em&gt; In vitro</em

The  apical and basolateral surfaces of airway epithelial cells demonstrate  directional responses to pathogen exposure in  vivo. Thus, ideal in vitro ...

Isolation of Myeloid Dendritic Cells and Epithelial Cells from Human Thymus

In this protocol we provide a method to isolate dendritic cells (DC) and epithelial cells (TEC) from the human thymus. DC and TEC are the major antigen presenting cell (APC) types found in a normal thymus and it is well established that they play distinct roles during thymic selection. These cells are localized in distinct microenvironments in the thymus and each APC type makes up only a minor population of cells. To further understand the biology of these cell types, characterization of these cell populations is highly desirable but due to their low frequency, isolation of any of these cell types requires an efficient and reproducible procedure. This protocol details a method to obtain cells suitable for characterization of diverse cellular properties. Thymic tissue is mechanically disrupted and after different steps of enzymatic digestion, the resulting cell suspension is enriched using a Percoll density centrifugation step. For isolation of myeloid DC (CD11c+), cells from the low-density fraction (LDF) are immunoselected by magnetic cell sorting. Enrichment of TEC populations (mTEC, cTEC) is achieved by depletion of hematopoietic (CD45hi) cells from the low-density Percoll cell fraction allowing their subsequent isolation via fluorescence activated cell sorting (FACS) using specific cell markers. The isolated cells can be used for different downstream applications.

This protocol details a method to isolate antigen presenting cells from human thymus via different steps of enzymatic digestion of the tissue followed by density centrifugation of the single cell suspension and finally magnetic and/or FACS sorting of the cell populations of interest.

Aislamiento de células dendríticas mieloides y células epiteliales de timo humano

In this protocol we provide a method to isolate dendritic cells (DC) and epithelial cells (TEC) from the human thymus. DC and TEC are the major antigen ...

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Antibodies against red blood cells (RBCs) can lead to complement activation resulting in an accelerated clearance via complement receptors in the liver (extravascular hemolysis) or leading to intravascular lysis of RBCs. Alloantibodies (e.g. ABO) or autoantibodies to RBC antigens (as seen in autoimmune hemolytic anemia, AIHA) leading to complement activation are potentially harmful and can be - especially when leading to intravascular lysis - fatal1. Currently, complement activation due to (auto)-antibodies on RBCs is assessed in vitro by using the Coombs test reflecting complement deposition on RBC or by a nonquantitative hemolytic assay reflecting RBC lysis1-4. However, to assess the efficacy of complement inhibitors, it is mandatory to have quantitative techniques. Here we describe two such techniques. First, an assay to detect C3 and C4 deposition on red blood cells that is induced by antibodies in patient serum is presented. For this, FACS analysis is used with fluorescently labeled anti-C3 or anti-C4 antibodies. Next, a quantitative hemolytic assay is described. In this assay, complement-mediated hemolysis induced by patient serum is measured making use of spectrophotometric&#160;detection of the released hemoglobin. Both of these assays are very reproducible and quantitative, facilitating studies of antibody-induced complement activation.

Here we describe two assays for measuring complement activation induced by antibodies against red blood cells. The major advantage over the current assays is their quantitative and easy-to-interpret nature.

Los métodos para la detección cuantitativa de anticuerpos inducida por la activación del complemento en los glóbulos rojos

Antibodies against red blood cells (RBCs) can lead to complement activation resulting in an accelerated clearance via complement receptors in the liver ...

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice

Regulatory T (Treg) cells, which express Foxp3 as a transcription factor, are subsets of CD4+ T cells. Treg cells play crucial roles in immune tolerance and homeostasis maintenance by regulating the immune response. The primary role of Treg cells is to suppress the proliferation of effector T (Teff) cells and the production of cytokines such as IFN-&#947;, TNF-&#945;, and IL-2. It has been demonstrated that Treg cells&#39; ability to inhibit the function of Teff cells is enhanced during persistent pathogen infection and cancer development. To clarify the function of Treg cells under resting or inflamed conditions, a variety of in vitro suppression assays using mouse or human Treg cells have been devised. The main aim of this study is to develop a method to compare the differences in phenotype and suppressive function between resting and activated Treg cells. To isolate activated Treg cells, mice were infected with lymphocytic choriomeningitis virus (LCMV) clone 13 (CL13), a chronic strain of LCMV. Treg cells isolated from the spleen of LCMV CL13-infected mice exhibited both the activated phenotype and enhanced suppressive activity compared with resting Treg cells isolated from na&#239;ve mice. Here, we describe the basic protocol for ex vivo phenotype analysis to distinguish activated Treg cells from resting Treg cells. Furthermore, we describe a protocol for the measurement of the suppressive activity of fully activated Treg cells.

Here, we describe a protocol to analyze the phenotype of regulatory T (Treg) cells isolated from na&#239;ve and chronic lymphocytic choriomeningitis virus-infected mice. In addition, we provide a process to evaluate the suppressive activity of the Treg cells.

El análisis fenotípico y funcional de las células reguladoras T activadas Aislado de la coriomeningitis linfocítica crónica por el virus ratones infectados

Regulatory T (Treg) cells, which express Foxp3 as a transcription factor, are subsets of CD4+ T cells. Treg cells play crucial roles in immune tolerance ...

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

This protocol describes noninvasive sampling of undisturbed upper airway mucosal lining fluid. It also details the extraction procedure used prior to the analysis of immune mediators in fluid eluates for the study of the airway topical immune signature, without the need for stimulation procedures (often used by other techniques). The mucosal lining fluid is sampled on a strip of filter paper placed at the anterior part of the inferior turbinate and left for 2 min of absorption. Analytes are eluted from the filter papers, and the extracted protein-based eluates are analyzed by an electrochemiluminescence-based immunoassay, allowing for the high-sensitivity quantification of low- and high-level analytes in the same sample. We measured the in vivo levels of 20 preselected immune mediators related to specific immune signaling pathways in the upper airway mucosa, but the technique is not limited to that specific panel or sampling site. The technique was first implemented in 7-year-old children from the Copenhagen Prospective Studies on Asthma in Childhood2000 (COPSAC2000) cohort with allergic rhinitis. It was thereafter used in the longitudinal COPSAC2010 birth cohort, sampled at 1 month, 2 years, and 6 years of age and at instances of acute respiratory symptoms. We successfully obtained and analyzed samples from 620 (89%) of 700 1-month-old children; a few samples were below the assay detection limit (reported as the median (Inter-Quartile Range (IQR)). The number of samples below the detection limit (i.e.&#160;from 0 to the set point for the lower limit of detection) for each mediator was 29 (7.25 - 119.5). This technique enables the quantification of the in vivo airway mucosal immune profile from birth, can be applied longitudinally, and can be applied to studies on the effect of genetics and early-life environmental exposures, pathophysiology, endotyping, and monitoring of respiratory diseases, and development and evaluation of novel therapeutics.

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

This protocol describes a noninvasive technique for the sampling of undisturbed mucosal lining fluid from the upper airways. It can be used to perform the quantification of in vivo levels of protein mediators, such as cytokines and chemokines, in subjects of all ages.

Muestreo no invasivo de revestimiento mucoso líquido para la cuantificación In Vivo de la vía aérea superior mediador inmune niveles

This protocol describes noninvasive sampling of undisturbed upper airway mucosal lining fluid. It also details the extraction procedure used prior to the ...

Isolation and Characterization of Neutrophil-derived Microparticles for Functional Studies

Polymorphonuclear neutrophil-derived microparticles (PMN)-MPs) are lipid bilayer, spherical microvesicles with sizes ranging from 50&#8211;1,000 nm in diameter. MPs are a newly evolving, important part of cell-to-cell communication and signaling machinery. Because of their size and the nature of their release, until recently MP existence was overlooked. However, with improved technology and analytical methods their function in health and disease is now emerging. The protocols presented here are aimed at isolating and characterizing PMN-MPs by flow cytometry and immunoblotting. Moreover, several implementation examples are given. These protocols for MP isolation are fast, low-cost, and do not require the use of expensive kits. Furthermore, they allow for the labeling of MPs following isolation, as well as pre-labeling of source cells prior to MP release, using a membrane-specific fluorescent dye for visualization and analysis by flow cytometry. These methods, however, have several limitations including purity of PMNs and MPs and the need for sophisticated analytical instrumentation. A high-end flow cytometer is needed to reliably analyze MPs and minimize false positive reads due to noise or auto-fluorescence. The described protocols can be used to isolate and define MP biogenesis, and characterize their markers and variation in composition under different stimulating conditions. Size heterogeneity can be exploited to investigate whether the content of membrane particles versus exosomes is different, and whether they fulfill different roles in tissue homeostasis. Finally, following isolation and characterization of MPs, their function in cellular responses and various disease models (including, PMN-associated inflammatory disorders, such as Inflammatory Bowel Diseases or Acute Lung Injury) can be explored.

New protocols are described here to isolate and characterize microparticles derived from human and mouse neutrophils. These protocols utilize ultracentrifugation, flow cytometry, and immunoblotting techniques to analyze microparticle content, and they can be used to study the role of microparticles derived from various cell types in cellular function.

Aislamiento y caracterización de micropartículas de neutrófilos derivado de estudios funcionales

Polymorphonuclear neutrophil-derived microparticles (PMN)-MPs) are lipid bilayer, spherical microvesicles with sizes ranging from 50&#8211;1,000 nm in ...

A Multi-well Format Polyacrylamide-based Assay for Studying the Effect of Extracellular Matrix Stiffness on the Bacterial Infection of Adherent Cells

Extracellular matrix stiffness comprises one of the multiple environmental mechanical stimuli that are well known to influence cellular behavior, function, and fate in general. Although increasingly more adherent cell types&#39; responses to matrix stiffness have been characterized, how adherent cells&#39; susceptibility to bacterial infection depends on matrix stiffness is largely unknown, as is the effect of bacterial infection on the biomechanics of host cells. We hypothesize that the susceptibility of host endothelial cells to a bacterial infection depends on the stiffness of the matrix on which these cells reside, and that the infection of the host cells with bacteria will change their biomechanics. To test these two hypotheses, endothelial cells were used as model hosts and Listeria monocytogenes as a model pathogen. By developing a novel multi-well format assay, we show that the effect of matrix stiffness on infection of endothelial cells by L. monocytogenes can be quantitatively assessed through flow cytometry and immunostaining followed by microscopy. In addition, using traction force microscopy, the effect of L. monocytogenes infection on host endothelial cell biomechanics can be studied. The proposed method allows for the analysis of the effect of tissue-relevant mechanics on bacterial infection of adherent cells, which is a critical step towards understanding the biomechanical interactions between cells, their extracellular matrix, and pathogenic bacteria. This method is also applicable to a wide variety of other types of studies on cell biomechanics and response to substrate stiffness where it is important to be able to perform many replicates in parallel in each experiment.

We have developed a multi-well format polyacrylamide-based assay for probing the effect of extracellular matrix stiffness on bacterial infection of adherent cells. This assay is compatible with flow cytometry, immunostaining, and traction force microscopy, allowing for quantitative measurements of the biomechanical interactions between cells, their extracellular matrix, and pathogenic bacteria.

Un ensayo de base poliacrilamida formato multi-bien para estudiar el efecto de la rigidez de la matriz extracelular en la infección bacteriana de las células adherentes